Amferia is a company headquartered in Sweden. Brouky records 2 investors associated with the company.
Amferia develops antimicrobial peptide-based medical devices and wound dressings that safely kill bacteria and address antibiotic resistance.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.